 |
7 Diseases |  |
1 Trial |
|
1 Trial |  |
41 News |  |
- | interferon alpha-2b Paradigm pump infusion system / Medtronic
Trial completion: The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol (clinicaltrials.gov) - Oct 3, 2019
P=N/A, N=79, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed
- ||| interferon alpha-2b Paradigm pump infusion system / Medtronic
Trial completion, Phase classification: Obtain a Good Blood Glucose Control With the Paradigm Real Time System (clinicaltrials.gov) - Dec 5, 2018
P=N/A, N=115, Completed, Sponsor: Medtronic Diabetes
Active, not recruiting --> Completed Recruiting --> Completed | Phase classification: P4 --> PN/A
- | interferon alpha-2b Paradigm pump infusion system / Medtronic
Phase classification: STAR3: Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=485, Completed, Sponsor: Medtronic Diabetes
Recruiting --> Completed | Phase classification: P4 --> PN/A Phase classification: P4 --> P=N/A
- | interferon alpha-2b Paradigm pump infusion system / Medtronic
Trial completion, Enrollment change, Trial primary completion date: Orchestra Pregnancy Observational Study in Poland (clinicaltrials.gov) - Nov 21, 2017
P=N/A, N=481, Completed, Sponsor: Medtronic Poland Sp
Phase classification: P4 --> P=N/A Recruiting --> Completed | N=350 --> 481 | Trial primary completion date: Feb 2017 --> Aug 2017
- || interferon alpha-2b Paradigm pump infusion system / Medtronic
Enrollment closed: The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol (clinicaltrials.gov) - Oct 23, 2017
P=N/A, N=79, Active, not recruiting, Sponsor: University of British Columbia
Recruiting --> Completed | N=350 --> 481 | Trial primary completion date: Feb 2017 --> Aug 2017 Recruiting --> Active, not recruiting
- | interferon alpha-2b Paradigm pump infusion system / Medtronic
Trial completion: Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm (clinicaltrials.gov) - Mar 30, 2017
P=N/A, N=50, Completed, Sponsor: Medtronic Diabetes
Recruiting --> Active, not recruiting Withheld --> Completed
- ||| interferon alpha-2b Paradigm pump infusion system / Medtronic
New trial: The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol (clinicaltrials.gov) - Jul 15, 2016
P=N/A, N=80, Recruiting, Sponsor: University of British Columbia
- interferon alpha-2b Paradigm pump infusion system / Medtronic
Enrollment change, Trial primary completion date: Orchestra Pregnancy Observational Study in Poland (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=350, Recruiting, Sponsor: Medtronic Poland Sp
Withheld --> Completed N=500 --> 350 | Trial primary completion date: Dec 2015 --> Feb 2017
- interferon alpha-2b Paradigm pump infusion system / Medtronic
Enrollment open: Orchestra Pregnancy Observational Study in Poland (clinicaltrials.gov) - Jul 21, 2013
P=N/A, N=500, Recruiting, Sponsor: Medtronic Poland Sp
N=500 --> 350 | Trial primary completion date: Dec 2015 --> Feb 2017 Not yet recruiting --> Recruiting
- |||| interferon alpha-2b Paradigm pump infusion system / Medtronic
Trial completion: COPE-HCV: Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (clinicaltrials.gov) - Dec 16, 2012
P2, N=116, Completed, Sponsor: Medtronic Corporate Technologies and New Ventures
Not yet recruiting --> Recruiting Active, not recruiting --> Completed